Quantum BioPharma Ltd. (QNTM) — Long-term Investment Intensity
Quantum BioPharma Ltd. (QNTM) has a Long-term Investment Intensity of 0.0% as of March 2025. Long-term investments of $2.22K represent 0.0% of total assets of $14.87 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check QNTM cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Quantum BioPharma Ltd. Long-term Investment Intensity (2020–2024)
This chart shows how Quantum BioPharma Ltd.'s Long-term Investment Intensity has evolved across 5 annual periods from 2020 to 2024. As of March 2025, the intensity stands at 0.0%, reflecting long-term investments of $2.22K against total assets of $14.87 Million USD. Explore how well can Quantum BioPharma Ltd. service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Quantum BioPharma Ltd. (2020–2024)
The table below presents the year-by-year Long-term Investment Intensity for Quantum BioPharma Ltd. from 2020 to 2024, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Quantum BioPharma Ltd..
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 0.0% | $2.22K | $17.12 Million | ▼ 0.0 pp |
| 2023 | 0.0% | $6.05K | $17.47 Million | ▼ -2.1 pp |
| 2022 | 2.2% | $827.61K | $38.41 Million | ▲ +1.1 pp |
| 2021 | 1.0% | $660.23K | $62.96 Million | ▼ -2.9 pp |
| 2020 | 4.0% | $1.68 Million | $41.97 Million | — |